Allstate Corp.

Allstate posted about $34.83 in adjusted diluted EPS for 2025 (and higher GAAP EPS); the shares still trade near single-digit trailing multiples.

If you own Allstate, you own a cheap insurer that still lives and dies by weather.

all

financials · insurance large cap updated feb 27, 2026
$207.51
market cap ~$54B · 52-week range $176–$217
xvary composite: 69 / 100 · average
our overall rating — combines growth, value, risk, and momentum
Start here if you're new
what it is
Allstate sells car, home, and life insurance, then tries to price risk better than the storms and drivers hitting its customers.
how it gets paid
Last year Allstate made $67.7B in revenue.
why it's growing
FY2025 total revenues rose about 5.6% to ~$67.7B. Q4 adjusted EPS of $14.31 vs. ~$8.01 consensus was a huge beat — underwriting and pricing finally showed through.
what just happened
Allstate printed $14.31 in fourth-quarter EPS, crushing the $8.01 consensus by 78.65%.
At a glance
A balance sheet — strong enough to weather a downturn
5/100 earnings predictability — expect surprises
5.9x trailing p/e — the market's not buying it — or you found a deal
2.0% dividend yield — cash in your pocket every quarter
15.8% return on capital — nothing to write home about
xvary composite: 69/100 — average
What they do
Allstate sells car, home, and life insurance, then tries to price risk better than the storms and drivers hitting its customers.
Allstate wins because it is huge, local, and still standing when smaller insurers get punched in the face by bad underwriting. It has about 54,000 employees and just $7.5 billion of long-term debt, which is 12% of capital. Debt-to-capital → how much of the business is financed by borrowing → so what: when losses spike, you want the insurer with room to keep writing policies.
insurance large-cap premiums pricing-power catastrophe-risk
How they make money
$67.7B annual revenue · FY2025 total revenues grew ~+5.6% YoY
total revenue
$67.7B
+5.6%
The products that matter
underwrites personal insurance
Auto, Home, and Life Insurance
$67.7B revenue · ~+5.6% FY growth
this $67.7B top line is consolidated Allstate revenue — your read-through is property-liability combined ratio, earned premium growth, and investment income, not a fake triple-digit growth rate.
the whole story
Key numbers
$25.20
2027 eps est
Forward estimates sit below FY2025’s adjusted print — the market expects mean reversion after an unusually strong underwriting year.
5.9x
trailing p/e
Price-to-earnings → how many dollars you pay for one dollar of profit → so what: you are paying a bargain multiple for a company with a 15% return on equity.
$7.5B
long-term debt
Long-term debt → money owed over many years → so what: at just 12% of capital, Allstate has room to absorb bad underwriting years without leaning on the balance sheet.
15.8%
return on capital
Return on capital → profit generated from the money running the business → so what: most insurers would love mid-teens returns with a 0.9 beta.
Financial health
A
strength
  • balance sheet grade A — very strong financial position
  • risk rank 2 — safer than 80% of stocks
  • price stability 85 / 100
  • long-term debt $7.5B (12% of capital)
  • return on equity 15% — $0.15 profit for every $1 investors have put in
A — among the top-rated companies for balance sheet quality.
Total return vs. market

You invested $10,000 in ALL 3 years ago → it's now worth $16,300.

The index would have given you $13,880.

source: institutional data · total return
What just happened
beat estimates
Allstate printed $14.31 in fourth-quarter EPS, crushing the $8.01 consensus by 78.65%.
Q4 total revenues ~$17.3B, up ~5.1% YoY. Property-Liability net premiums earned rose ~6.1% to ~$14.8B; combined ratio 72.9. FY2025 adjusted diluted EPS ~$34.83 vs. ~$16.99 in 2024 per recap materials.
$17.3B
revenue
$14.31
eps
5.0%
revenue growth
the number that mattered
The 78.65% EPS beat mattered because it showed pricing is finally outrunning claims, which is the whole job in insurance.
source: Allstate Q4 & FY2025 materials (newsroom) · Feb 2026

Get this snapshot in your inbox

This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.

weekly updates earnings alerts plain english no spam
What could go wrong

the top risk for your ALL position is the 72.9% combined ratio proving unsustainably good.

!
high
earnings normalization
FY2025 adjusted diluted EPS was ~$34.83, but FY2026 is estimated near $25 — mean reversion risk.
that's the market telling you a big part of the rebound may not repeat. if underwriting margins cool, the stock's 5.9x trailing multiple is less of a bargain than it looks.
!
high
litigation overhang
a US judge approved a $25M class-action settlement in may 2024, and other legal proceedings remain pending.
$25M is small against $67.7B of revenue, but recurring legal noise can pressure valuation because it adds uncertainty to a business investors already see as hard to forecast.
Expected FY2026 EPS near $25 versus ~$34.83 adjusted in FY2025 is the real warning label. the legal bill is manageable. the bigger risk is that peak underwriting margins fade.
source: institutional data · regulatory filings · risk analysis
Pay attention to
catalyst
whether FY2026 really drops to $25.00 EPS
the stock can handle slower growth. it does not want a collapse from ~$35 adjusted EPS to something worse than current estimates.
metric
combined ratio trend
72.9% was exceptional. if that starts drifting up, you'll know the rebound story is losing force.
metric
premium growth rate
property-liability premiums were up 6% to $14.8B. you want pricing and volume to keep working together, not take turns.
metric
institutional flow
three straight quarters of net buying help. if that flips while estimates fall, the market is telling you the easy part of the rerating is over.
Analyst rankings
short-term outlook
average
momentum score 3 — the stock is moving with the broader market. in human-speak: no big short-term signal.
risk profile
safer than most
stability score 2 — safer than roughly 80% of stocks. the balance sheet looks sturdier than the earnings line.
chart momentum
top 20%
technical score 2 — analysts expect above-average price performance in the year ahead.
earnings predictability
5 / 100
very low predictability. for insurers, one clean underwriting year can make the numbers look neater than the business really is.
source: institutional data
Institutional activity

institutions have been net buying for 3 consecutive quarters — 694 buyers vs. 612 sellers in 3q2025. total institutional holdings: 0.2B shares. net buying for 3 quarters.

source: institutional data
Price targets
3-5 year target range
$175 $341
$208 current price
$258 target midpoint · +24% from current · 3-5yr high: $385 (+85% · 18% ann'l return)
source: institutional data · analyst targets

Want the deeper analysis?

The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.

see plans from $5/mo
The deep dive
ALL
xvary deep dive
all
the full analysis is in the works.
what you'll get
dcf valuation model
bull / base / bear scenarios
competitive moat breakdown
quarterly earnings tracker
operating model projections
risk matrix with kill criteria
original price target + conviction
updated with every earnings
free · no spam · you'll be first to read it